![Rogério Vivaldi Coelho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 2 Mio $ am 31.07.2026
Rogério Vivaldi Coelho was the founder of Minerva Neurosciences, Inc., founded in 2007, where the title held was President, Chief Executive Officer & Director in 2014.
Current jobs include Independent Director at Crinetics Pharmaceuticals, Inc. since 2022 and Independent Director at Viatris, Inc. since 2024.
Former jobs include President, Chief Executive Officer & Director at Sigilon Therapeutics, Inc. from 2022 to 2023; Director at Mind-NRG SARL in 2014; President-Rare Disease, Renal & Endocrine, SVP at Genzyme Corp.
from 1997 to 2014; Chief Commercial Officer at Spark Therapeutics, Inc. from 2015 to 2016; and Chief Global Therapeutics Officer & Executive VP at Bioverativ, Inc. from 2016 to 2018.
Education includes a doctorate from the Federal University of Rio de Janeiro and an MBA from COPPEAD Graduate School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.07.2026 | 13’300 ( 0.01% ) | 1 Mio $ | 31.07.2026 | |
| 26.03.2026 | 46’526 ( 0% ) | 816 997 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 03.01.2022 |
| VIATRIS INC. | Direktor/Vorstandsmitglied | 03.06.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01.01.2018 |
| SPARK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.01.2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| MINERVA NEUROSCIENCES, INC. | Gründer | 20.11.2014 |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Direktor/Vorstandsmitglied | 20.11.2014 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Federal University of Rio de Janeiro
 Federal University of Rio de Janeiro Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Health Services |
COPPEAD Graduate School of Business
 COPPEAD Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
